The impact of early neuraminidase inhibitor therapy on clinical outcomes in patients hospitalised with influenza A-related pneumonia: a multicenter, retrospective study

Table 3 The impact of early NAI therapy on the clinical outcomes of FluA-CAP patients

Variable	Patients (n, %)		Univariate logistic analysis		Multivariate logistic analysis
Variable	Early NAI use group (n = 232)	Control group (n = 461)	OR (95% CI)	p-value	^aaOR (95% CI)	p-value
Invasive ventilation	52 (22.4)	106 (23.0)	0.897 (0.612–1.317)	0.577	0.511 (0.312–0.835)	0.007
14-day mortality	32 (13.8)	48 (10.4)	1.377 (0.853–2.221)	0.190	0.477 (0.124–0.744)	< 0.001
30-day mortality	60 (25.9)	76 (16.5)	1.767 (1.205–2.592)	0.004	0.533 (0.210–0.807)	< 0.001

^aAdjusted for weighted propensity scores for treatment, systemic corticosteroid and antibiotic use

ISSN: 1471-2334